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Non-insulin Dependent Diabetes Mellitus (NIDDM) 
or Type 2 diabetes constitutes, nearly 95-97% of all 
diabetic patients in most population groups. The 
prevalence of NIDDM varies considerably from 
<1% in some countries to 50% in certain 
populations and developing countries like Pima 
Indians and Micronesians[1]. The prevalence of 
diabetes in India is very rapidly rising and it is 
estimated that by the year 2010 A.D, 20% of all 
Type 2 patients in the world would be contributed 
from India. This form of diabetes till recently was 
considered as a mild diabetes or "a touch of 
diabetes" and obviously the management stratagies 
were less vigorous. Recently published studies[2,3] 
have proved beyond doubt, that tight control of 
diabetes definitely prevents or slows down the 
progression of late complications of diabetes. 
Diabetes mellitus basically produces changes in the 
blood vessels and hence can affect almost every part 
of the body. It is known that diabetes mellitus is a 
leading cause of acquired blindness in the developed 
countries. It carries 2-3 times higher risk of heart 
attacks and an even higher risk for stroke. Diabetics 
are at 5 times higher risk to develop nephropathy 
and an estimated 25% of all new cases of end stage 
renal diseases are the result of diabetes. Diabetic 
patients are five times more prone to gangrene and 
diabetes accounts for 50% of all non traumatic 
complications[4]. The onset Type 2 diabetes is 
usually insidious and the patient may remain 
asymptomatic until late stages of the diseases. 
Hence one should aim to make an early diagnosis in 
order to reduce the morbidity and prevent the 
progression to end-stage complications. Thus, it is 
necessary to screen for all complications at the time 
of diagnosis of diabetes.  
 
The late complications of diabetes can be broadly 
classified as 
 
1. Microangiopathy - Retinopathy 
                                - Nephropathy 
 
2. Macroangiopathy - Coronary Heart Disease 
                                   Peripheral Vascular Disease 
                                   Cerebrovascular Disease 
 
 
 
 
 
3. Neuropathy - Peripheral Neuropathy 
                          Autonomic Neuropathy 
 
In this review, we will be dealing with the 
prevalence of complications at diagnosis of Type 2 
diabetes based on our clinical and epidemiological 
studies done at the Madras Diabetes Research 
Foundation and M.V. Diabetes Specialities Centre, 
Chennai.  
 
DIABETIC RETINOPATHY 
 
Diabetic Retinopathy is perhaps the most specific of 
all diabetic complications. The prevalence of 
Retinopathy is related to the duration of diabetes. 
Rema et al[4] studied the prevalence of retinopathy 
in 6792 NIDDM patients seen at M.V Diabetes 
Specialities Centre at Chennai. The overall 
prevalence of retinopathy was 34.2% of which 
30.8% was NPDR (Non –proliferative Diabetic 
Retinopathy) and 3.4% PDR (Proliferative Diabetes 
Retinopathy). In the same study, the prevalence of 
NPDR and PDR were 7.2% and 0.2% at the onset of 
diabetes which increased to 73% and 11.9% after 20 
years duration of diabetes. These figures are lower 
than those reported by other workers[5]. In most 
western studies the prevalence of retinopathy at 
diagnosis varies from 20-30%. The reason for these 
differences are not clear. Klein et al[6] using retinal 
photography reported that 23% of their patients had 
retinopathy in those with less than 2 years duration 
of diabetes. It was felt that the lower prevalence 
rates of retinopathy in our first study may be due to 
lower sensitivity of clinical examination. Hence a 
study was taken up by Rema et al[8] to assess the 
prevalence of retinopathy at diagnosis in south 
Indian NIDDM patients using retinal photography. 
A total of 300 newly diagnosed NIDDM patients 
attending MVDSC were assessed by both clinical 
(direct and indirect ophthalmoscopy) and by retinal 
photography after full mydriasis using a 50 -VT 
Topcon retinal camera. Four standard fields 
including stereo photographs of the macula were 
taken using 35mm colour transparencies. 
Photographs were graded using modification of the 
Early Treatment Diabetic Retinopathy study 
(ETDRS) classification system[7]. 7.9% of newly 
diagnosed NIDDM patients had retinopathy which   
included   6.9%   of    early   background   diabetic  
 
* From M.V. Diabetes Specialities Centre, Chennai. 
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retinopathy and 1% with maculopathy. In this series 
none had proliferative diabetic retinopathy. The 
results were presented at the IDF congress congress 
at Helsinki[8] and are shown in Table 1.  
 
Table 1 
 
Prevalence of Retinopathy at Diagnosis in NIDDM 
by Photographic Assessment [Rema et al 8] 
 
Grade Number Prevalence rate 
(in percent) 
Early BDR 22 6.9% 
BDR with 
maculopathy 
3 1.0% 
Total BDR 25 7.9% 
PDR 0 0% 
  
Comparison of retinopathy rates across different 
countries is difficult because of differences in type 
of diabetes, number of patients studied and the 
different methods used for screening. Inspite of high 
prevalence rate of diabetes in South India, the 
slightly lower prevalence of retinopathy at onset of 
Type 2 diabetes compared to European is of interest 
and obviously more studies are needed from 
different parts of India. 
 
PREVALENCE OF ISCHAEMIC HEART 
DISEASE 
 
In an earlier study we have shown that the 
prevalence of ischaemic heart disease is high in 
South Indian NIDDM patients[9]. To assess the 
prevalence of IHD at diagnosis in NIDDM patients, 
we took up a study of 4471 newly diagnosed 
NIDDM patients seen at the M.V. Diabetes 
Specialities Centre. Criteria for Diagnosis was based 
on the clinical history and physical examination. All 
patients had a resting 12 lead computerised 
electrocardiogram. The definitions for IHD used 
were:  
 
1. Myocardial Ischaemia: History of classical 
chest pain and/or unequivocal ECG changes 
suggestive of ischaemia but no evidence of 
infarction.  
 
2. Infarction: A definite history of myocardial 
infarction and/or unequivocal changes of E.C.G. 
suggestive of a recent or past myocardial 
infarction.  
The overall prevalence of IHD at diagnosis of Type 
2 diabetes in this series was 7.9% of which 6% had 
ischaemia and 1.9% patients had infarction (Table 
2). 
 
Table 2 
 
Prevalence of IHD and PVD at diagnosis in 
NIDDM 
Prevalence  
of IHD 
Numbers Prevalence  
Ischaemia 272/4471 6.1% 
Infarction 86/4471 1.9% 
Total IHD 358/4471 7.9% 
Prevalence of PVD  24/3371 0.71% 
  
This study thus confirms earlier reports that while 
the prevalence of IHD is high, that of PVD is low 
[10.11] 
 
PREVALENCE OF PERIPHERAL VASCULAR 
DISEASE 
 
The prevalence of peripheral vascular disesase was 
studied in 3371 new diagnosed patients seen at the 
M.V.Diabetes Specialities Centre. Peripheral 
vascular disease was diagnosed clinically, if there 
was a history of intermittent claudication or rest 
pain and both dorsalis pedis and posterior tibial 
pulsations were absent in the same foot or one of 
these pulses were absent in both feet. Doppler 
studies were done using the KODY Vaslab machine 
and ankle/brachial (A/B) index was calculated. An 
(A/B) index of 0.8 or less was used for diagnosis of 
PVD by doppler criteria. In contrast to IHD, the 
prevalence of PVD was only 0.7 at the time of 
diagnosis of NIDDM. The results are tabulated in 
Table 2 
  
EPIDEMIOLOGICAL STUDIES ON IHD AND PVD 
 
The above studies were done at our centre, a 
specialised hospital and it could be argued that the 
data may be subject to a lot of referral bias. To 
avoid this bias, we recently took up population 
based studies to find out the prevalence of IHD and 
PVD in the population. The study was carried out in 
three residential colonies in different part of the 
Chennai city representing low, middle and upper 
income groups. 
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A resting 12-lead ECG (Minnesota coded) and 
peripheral doppler studies were done in a total of 
955 individuals. According to this study, 17.8% of 
the over all population had CHD and 20.4% of 
diabetics had CHD. The prevalence of PVD was 
low in all three groups, overall prevalence in the 
population was 1.05% and 2.3% among diabetic 
subjects [12]. Thus our population based data once 
again confirms that prevalence of IHD is high while 
that of PVD is low among the South Indian 
population studied by us. 
 
AUTONOMIC DYSFUNCTION IN NIDDM 
 
It is interesting to note that significant autonomic 
neuropathy is present even at onset of diabetes. In 
support of this Ratzmann et al[13] have recently 
shown that in a cohort of "newly diagnosed 
NIDDM", autonomic dysfunction was see in 2.1% - 
7.3% of patients. It is possible that the actual 
duration of diabetes is longer because of the 
insidious nature of the disease. Estimates of the 
prevalence of autonomic dysfunction based on 
presence of abnormalities of cardiovascular 
autonomic reflexes have ranged from 14% to 66%. 
Veglio et al [14] in a study of 221 NIDDM patients 
found that 66% had at least one abnormal 
cardiovascular autonomic test. They found a 
correlation with age but not with duration of 
diabetes or metabolic control. 
  
The prevalence of autonomic dysfunction in 
NIDDM patients seen at our centre was reported in 
1996[15]. The study group comprised of 336 
NIDDM attending MVDSC, which included every 
fifth NIDDM patient registered at our centre. A 
battery of five standard tests of autonomic 
dysfunction i.e. three tests of heart rate responses 
and two tests of blood pressure responses and two 
tests of blood pressure responses to different 
manoeuvres were done using protocols 
recommended by Ewing and Clarke[16] which are 
outlined in Table 3. The tests were done using a 
computerised electrocardiograph machine with an 
in-built programme for performing computerised R-
R interval analysis. The machine automatically 
calculates the mean of approximately 100 R-R 
measurements and provides the minimum R-R, 
maximum R-R, and the co-efficient of variation of 
R-R (CV of R-R) for each of the parameters used. 
  
The prevalence of autonomic dysfunction was 
studied in relation to the age of patients and duration 
of diabetes. There was no evidence of autonomic 
neuropathy dysfunction below the age of 20 years 
and there was a steady increase reaching upto 50% 
prevalence after 60 years of age. Similarly the 
prevalence after 60 years of age. Similarly the 
prevalence increased with increased duration of 
diabetes. 28.2% of NIDDM patients with duration 
of <5 years had autonomic dysfunction which 
increased to 56.2% with duration of >20 years. 
  
CONCLUSIONS 
  
In summary, prevalence of complications is quite 
high even at the time of diagnosis of Type 2 
diabetes (NIDDM). This is probably because of the 
insidious onset of diabetes and long duration of 
asymptomatic disease before symptoms develop. 
Hence screening tests for complications are strongly 
recommended at the time of diagnosis not only for 
early detection, but also to prevent the progression 
to end-stage disease. 
  
Table 3 
 
Normal Values for Autonomic Nervous System 
Tests. 
  Coefficient of Variation 
Heart Rate Tests Control  
(Mean ± S.D.)  
Abnormal 
Value 
Heart rate response  
To Valsalva 
13.2 ± 5.0 < 3.2 
Heart rate variation  
During deep breathing 
11.3 ± 4.4  < 2.5 
Heart rate response  
to standing 
6.5 ± 2.4 < 1.7 
Blood Pressure  
Tests 
    
Blood pressure response 
to standing (fall in 
systolic BP) 
Less than  
10 mm 
More 
than  
20 mm 
Blood pressure response 
to sustained hand grip 
(increase in diastolic BP) 
More than  
20 mm 
Less than  
10 mm 
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